We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CMS Proposes Limited Coverage of Prolaris Prostate Cancer Test
CMS Proposes Limited Coverage of Prolaris Prostate Cancer Test
The Centers for Medicare & Medicaid Services is willing to pay for Myriad Genetics’ Prolaris prostate cancer test via a local coverage determination proposed by a South Carolina Medicare contractor.